36 results
8-K/A
EX-99.3
CRVO
CervoMed Inc
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
” refer to the business of CervoMed Inc.
Overview
We are a clinical stage therapeutics company that is developing treatments for acute and chronic … disease. Chronic activation of the enzyme, p38 mitogen-activated protein kinase (“MAPK”) alpha (“p38α”) in the neurons (nerve cells) within the brains
8-K/A
EX-99.1
0a9b1k2e
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
EX-99.1
rl45hr1
6 Sep 23
Other Events
4:05pm
8-K
cy3ezk jpq
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
425
vlr buxyk5g
3 Aug 23
Business combination disclosure
4:15pm
8-K
9qkaspqspp9cm1 qyng
3 Aug 23
Other Events
4:15pm
425
sy41zrnf
31 Jul 23
Business combination disclosure
5:20pm
8-K
9cgn7fhc7ahj2gh
31 Jul 23
Entry into a Material Definitive Agreement
5:19pm
424B3
zxxj1cphsl
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
q8ndd
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
emivnc t26zt0c9a61
10 May 23
Registration of securities issued in business combination transactions
9:56pm
PRRN14A
kmk105yyf9t923o
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
PRRN14A
6oajqfkw
2 Dec 22
Revised preliminary proxy statement filed by non-management
2:36pm
PREC14A
erm8ihdd
23 Nov 22
Preliminary proxy with contested solicitation
11:26am